Fricker SP - Search Results

1

Teicher BA, Fricker SP. Teicher BA, et al. Among authors: fricker sp. Clin Cancer Res. 2010 Jun 1;16(11):2927-31. doi: 10.1158/1078-0432.CCR-09-2329. Epub 2010 May 18. Clin Cancer Res. 2010. PMID: 20484021 Review.

2

A novel CXCR4 antagonist for hematopoietic stem cell mobilization.

Fricker SP. Fricker SP. Expert Opin Investig Drugs. 2008 Nov;17(11):1749-60. doi: 10.1517/13543784.17.11.1749. Expert Opin Investig Drugs. 2008. PMID: 18922110 Review.

3

Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G, Balkwill FR. Scotton CJ, et al. Cancer Res. 2002 Oct 15;62(20):5930-8. Cancer Res. 2002. PMID: 12384559

4

Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.

O'Boyle G, Swidenbank I, Marshall H, Barker CE, Armstrong J, White SA, Fricker SP, Plummer R, Wright M, Lovat PE. O'Boyle G, et al. Among authors: fricker sp. Br J Cancer. 2013 Apr 30;108(8):1634-40. doi: 10.1038/bjc.2013.124. Epub 2013 Mar 28. Br J Cancer. 2013. PMID: 23538388 Free PMC article.

5

Chemokine receptor modeling: an interdisciplinary approach to drug design.

Fricker SP, Metz M. Fricker SP, et al. Future Med Chem. 2014 Jan;6(1):91-114. doi: 10.4155/fmc.13.194. Future Med Chem. 2014. PMID: 24358950 Review.

6

CXCR₄antagonism as a therapeutic approach to prevent acute kidney injury.

Zuk A, Gershenovich M, Ivanova Y, MacFarland RT, Fricker SP, Ledbetter S. Zuk A, et al. Among authors: fricker sp. Am J Physiol Renal Physiol. 2014 Oct 1;307(7):F783-97. doi: 10.1152/ajprenal.00685.2013. Epub 2014 Jul 30. Am J Physiol Renal Physiol. 2014. PMID: 25080523 Free article.

7

Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors.

Wong RS, Bodart V, Metz M, Labrecque J, Bridger G, Fricker SP. Wong RS, et al. Among authors: fricker sp. Mol Pharmacol. 2008 Dec;74(6):1485-95. doi: 10.1124/mol.108.049775. Epub 2008 Sep 2. Mol Pharmacol. 2008. PMID: 18768385

8

Characterization and Validation of Antibodies for Immunohistochemical Staining of the Chemokine CXCL12.

Fricker SP, Sprott K, Spyra M, Uhlig P, Lange N, David K, Wang Y. Fricker SP, et al. J Histochem Cytochem. 2019 Apr;67(4):257-266. doi: 10.1369/0022155418818788. Epub 2018 Dec 18. J Histochem Cytochem. 2019. PMID: 30562126 Free PMC article.

9

Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4.

Fricker SP, Anastassov V, Cox J, Darkes MC, Grujic O, Idzan SR, Labrecque J, Lau G, Mosi RM, Nelson KL, Qin L, Santucci Z, Wong RS. Fricker SP, et al. Biochem Pharmacol. 2006 Aug 28;72(5):588-96. doi: 10.1016/j.bcp.2006.05.010. Epub 2006 Jul 3. Biochem Pharmacol. 2006. PMID: 16815309

10

Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.

Bodart V, Anastassov V, Darkes MC, Idzan SR, Labrecque J, Lau G, Mosi RM, Neff KS, Nelson KL, Ruzek MC, Patel K, Santucci Z, Scarborough R, Wong RS, Bridger GJ, Macfarland RT, Fricker SP. Bodart V, et al. Among authors: fricker sp. Biochem Pharmacol. 2009 Oct 15;78(8):993-1000. doi: 10.1016/j.bcp.2009.06.010. Epub 2009 Jun 18. Biochem Pharmacol. 2009. PMID: 19540208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page